Are two antidepressants always better than one?

Progress in Neurology and Psychiatry

Volumn 16, Issue 3, 2012, Pages 5-8

  Feetam, Celia ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; FLUOXETINE; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL PRACTICE; DEPRESSION; DOPAMINERGIC TRANSMISSION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; HYPERTENSIVE CRISIS; MAJOR DEPRESSION; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC TRANSMISSION; SOCIAL CARE; TREATMENT OUTCOME;

EID: 84862598386     PISSN: 13677543     EISSN: 1931227X     Source Type: Journal    
DOI: 10.1002/pnp.234     Document Type: Review

References (21)

1. WHO: The Global Burden of Disease 2004 Update 2008. Available at Accessed December http://www.who.int/healthinfo/global_burden_disease/ 2004_report_update/en 2011.
2. McManus S, Meltzer H, Brugha T, et al. Adult psychiatric morbidity in England, 2007: Results of a household survey. National Centre for Social Research. Available at Accessed December: http://www.ic.nhs.uk 2011
3. McCrone P, Dhanasiri S, Patel A, et al. Paying the Price: The cost of mental health care in England to 2026. The Kings Fund, 2008. Available at Accessed December : http//www.kingsfund.org.uk/publications/paying _the_price.html 2011.
4. Lee AS, Murray RM. The long-term outcome of Maudsley depressives. Br J Psychiatry 1988;153:741-51.
5. Winokur G, Coryell W, Keller M. A prospective study of patients with bipolar and unipolar affective disorder. Arch Gen Psychiatry 1993; 50:457-65.
6. National Institute for Health and Clinical Excellence. CG90 Clinical Guideline. Depression: Management of depression in primary and secondary are. London: NICE, 2009. Available at: Accessed December 2011.www.nice.org.uk
7. Nierenberg AA, Amsterdam JD. Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 1990;51:39-47.
8. Keller MB, Lavori PW, Rice J, et al. The persistent risk of chronicity in recurrent episodes of non-bipolar major depressive disorder: a prospective followup. Am J Psychiatry 1986;143:24-8
9. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or more treatment steps; A STAR*D report. Am J Psychiatry 2006;163(11):1905-17.
10. Anderson IM, Ferrier IN, Baldwin RC, et al.. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacology 2008;22(4):343-96.www.bap.org.uk Accessed December 2011.
11. Palaniyappan L, Insole L, Ferrier IN. Combining antidepressants: a review of the evidence. Adv Psychiatr Treat 2009;15:90-9.
12. Stryjer R, Spivak B, Strous RD, et al. Trazodone for the treatment of sexual dysfunction induced by serotonin uptake inhibitors: a preliminary open-label study. Clin Neuropharmacol 2009;32:82-4.
13. Feetam CL. Medicine taking behaviour in depression - parts 1 and 2. Progress in Neurology and Psychiatry 2009;13,13(1,2):21-3
14. Dodd S, Horgan D, Malhi GN, Berk M. To combine or not to combine? A literature review of antidepressant combination therapy. J Affective Disorders 2005;89:1-11.
15. McGrath PJ, Stewart JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry 2006;163:1531-41.
16. Aydemir O, Taskin EO, Deveci A. Mirtazapine augmentation in treatment-resistant major depressive disorder: an open label, six week trial. Eur Neuropsychopharmacol 2005;15(Suppl):401-2.
17. Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biological Psychiatry 2002;51:183-8.
18. Hannan N, Hamzah Z, Akinpeloye HO, Meagher D. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness. J Psychopharmacol 2007;21:161-4.
19. Blier P, Ward HE, Tremblay P, et al. Combination antidepressant medications from treatment initiation for major depressive disorder: A double blind randomised study. Am J Psychiatry 2010;167:281-8.
20. Rush AJ, Trivedi MH, Stewart JW, et al.Combining medications to enhance depression outcomes (CO-MED): Acute and long term outcomes of a single-blind randomized study. Am J Psychiatry 2011;168:689-701.
21. Trivedi MH, Rush AJ, Kurian BT, et al. Letters to the Editor. Am J Psychiatry 2012;169:95-6.